137 related articles for article (PubMed ID: 10649492)
1. Sequence variants of DLC1 in colorectal and ovarian tumours.
Wilson PJ; McGlinn E; Marsh A; Evans T; Arnold J; Wright K; Biden K; Young J; Wainwright B; Wicking C; Chenevix-Trench G
Hum Mutat; 2000; 15(2):156-65. PubMed ID: 10649492
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
3. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
4. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.
Hewitt C; Wilson P; McGlinn E; MacFarlane G; Papageorgiou A; Woodwards RT; Sloan P; Gollin SM; Paterson I; Parkinson KK; Read AP; Thakker N
Cancer Lett; 2004 Jun; 209(2):207-13. PubMed ID: 15159023
[TBL] [Abstract][Full Text] [Related]
5. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.
Johnstone CN; Castellví-Bel S; Chang LM; Bessa X; Nakagawa H; Harada H; Sung RK; Piqué JM; Castells A; Rustgi AK
Gene; 2004 Jul; 336(1):59-71. PubMed ID: 15225876
[TBL] [Abstract][Full Text] [Related]
6. Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer.
Liu Y; Emilion G; Mungall AJ; Dunham I; Beck S; Le Meuth-Metzinger VG; Shelling AN; Charnock FM; Ganesan TS
Oncogene; 2002 Jan; 21(3):387-99. PubMed ID: 11821951
[TBL] [Abstract][Full Text] [Related]
7. Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer.
Gustafson CE; Wilson PJ; Lukeis R; Baker E; Woollatt E; Annab L; Hawke L; Barrett JC; Chenevix-Trench G
Cancer Res; 1996 Nov; 56(22):5238-45. PubMed ID: 8912863
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
9. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
[TBL] [Abstract][Full Text] [Related]
10. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.
Wright K; Wilson PJ; Kerr J; Do K; Hurst T; Khoo SK; Ward B; Chenevix-Trench G
Oncogene; 1998 Sep; 17(9):1185-8. PubMed ID: 9764830
[TBL] [Abstract][Full Text] [Related]
12. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
Hornigold N; Devlin J; Davies AM; Aveyard JS; Habuchi T; Knowles MA
Oncogene; 1999 Apr; 18(16):2657-61. PubMed ID: 10353610
[TBL] [Abstract][Full Text] [Related]
14. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
15. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3.
Cunningham C; Dunlop MG; Wyllie AH; Bird CC
Oncogene; 1993 May; 8(5):1391-6. PubMed ID: 8479756
[TBL] [Abstract][Full Text] [Related]
16. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
17. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.
Yuan BZ; Miller MJ; Keck CL; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 1998 May; 58(10):2196-9. PubMed ID: 9605766
[TBL] [Abstract][Full Text] [Related]
18. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
19. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
20. WWOX: a candidate tumor suppressor gene involved in multiple tumor types.
Paige AJ; Taylor KJ; Taylor C; Hillier SG; Farrington S; Scott D; Porteous DJ; Smyth JF; Gabra H; Watson JE
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11417-22. PubMed ID: 11572989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
